{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:22:29Z","timestamp":1788182549934,"version":"build-2803163510"},"reference-count":31,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Background: Streptococcus suis (S. suis) is a significant zoonotic pathogen, with serotype 2 (SS2) being the most prevalent. Suilysin (SLY), an essential toxin indicator for S. suis, is crucial in the infections caused by SS2. Consequently, an anti-virulence strategy targeting SLY presents a promising approach to combat SS2. Objectives: To investigate the effect of curcumin, a naturally occurring phenolic compound, on the hemolytic activity of SLY and the pathogenicity of SS2, and to assess its viability as a novel anti-virulence candidate for addressing SS2 infections. Methods: The antibacterial activity of curcumin against SS2 was assessed by determining its minimal inhibitory concentration (MIC) and monitoring bacterial growth curves. Its impact on hemolytic activity was tested using supernatants from SS2 cultures and purified recombinant SLY protein. Western blot was used to determine if curcumin affected the secretion level of SLY. The interaction between curcumin and SLY was predicted using molecular docking. Finally, the protective efficacy of curcumin was evaluated in a murine model of lethal SS2 infection. Results: Curcumin (&lt;1,024 ?g\/mL) did not inhibit SS2 growth or viability. However, it significantly and dose-dependently inhibited the hemolytic activity of both SS2 culture supernatants and purified SLY. Molecular docking predictions indicated that curcumin engaged three domains of SLY (D1, D2 and D3) simultaneously, forming five hydrogen bonds with residues ASN-50, GLN-107 and LYS-190, thereby supporting its multidomain-binding capability. Furthermore, curcumin administration significantly reduced the mortality of SS2-infected mice in vivo. Conclusion: Substantial evidence is presented demonstrating that the pathogenicity of SS2 can be effectively attenuated by curcumin via inhibition of the hemolytic activity of SLY, which supports the potential utility of curcumin as a host-directed anti-virulence agent for SS2 infections.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.7.210.1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:14:22Z","timestamp":1779362062000},"source":"Crossref","is-referenced-by-count":0,"title":["Curcumin Reduces The Pathogenicity Of Streptococcus Suis Serotype 2 In Mice By Targeting Suilysin"],"prefix":"10.36721","author":[{"given":"Jiafei","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Breitfelder A, Sattler T, Kauffold J, Pfetzing S, Majcher A, Ulrich R, M\u00fcller U, \u00d6hlmann S, Rieckmann K and Baums C (2025). A new lymph node infection model for Streptococcus suis serotype 2 in pigs. Vet. Res., 56: 186.","DOI":"10.1186\/s13567-025-01616-7"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Dong N, Nichols H, Sun Q, Chen X, Zheng J, Guan Z, Zhang H, Davison A, Wezel Y, Li Z, Li B, Liu K, Shao D, Qiu Y, Sun J, Li X, Upton M, Ma Z, Jarvis MA and Wei J (2023). Bovine herpesvirus-4 based vaccine provides protective immunity against Streptococcus suis disease in a rabbit model. Vaccines (Basel), 11(5): 1004.","DOI":"10.3390\/vaccines11051004"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Eiamphungporn W, Laohabutr P, Kaewsai N, Pornsuwan S, Yainoy S and Chatupheeraphat C (2025).  Development of a recombinase polymerase amplification nucleic acid lateral flow assay for detecting Streptococcus suis serotype 2 in pork. Sci. Rep., 15(1): 10442.","DOI":"10.1038\/s41598-025-95480-2"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Fu Y, Jie J, Lei L, Liu M, Wang J and Lei L (2024). Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability. Microbiol. Spectr., 12(8): e0061224.","DOI":"10.1128\/spectrum.00612-24"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gao S, Quan Y, Song S, Jin W, Chang Z, Liu B, Wang Y, Yi L and Wang Y (2025). Disrupting bacterial metabolism by targeting LDH reverses Streptococcus suis aminoglycoside resistance. Int. J. Antimicrob. Agents., 66(6): 107599.","DOI":"10.1016\/j.ijantimicag.2025.107599"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Gottschalk M, Segura M and Xu J (2007). Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev., 8(1): 29-45.","DOI":"10.1017\/S1466252307001247"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Gu Y, Wang S, Huang L, Sa W, Li J, Huang J, Dai M and Cheng G (2020). Development of resistance in Escherichia coli ATCC25922 under exposure of sub-inhibitory concentration of olaquindox. Antibiotics (Basel), 9(11): 791.","DOI":"10.3390\/antibiotics9110791"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Guo G, Kong X, Du D, Wei D and Zhang W (2021). Genome-wide association study identifies the virulence-associated marker in Streptococcus suis serotype 2. Infect. Genet. Evol., 92(8): 104894.","DOI":"10.1016\/j.meegid.2021.104894"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Han N, Li J, Zhao F, Li Y, Wang J, Dai X, Zeng D, Xiong W and Zeng Z (2023). Isopropoxy benzene guanidine ameliorates Streptococcus suis infection in vivo and in vitro. Int. J. Mol. Sci., 24(8): 7354.","DOI":"10.3390\/ijms24087354"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lafrance ME, Farrow MA, Chandrasekaran R, Sheng J, Rubin DH and Lacy DB (2015). Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc. Natl. Acad. Sci. USA., 112(22): 7073-7078.","DOI":"10.1073\/pnas.1500791112"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Li G, Lu G, Qi Z, Li H, Wang J, Wang Y, Liu B, Niu X, Deng X and Wang J (2017). Morin attenuates Streptococcus suis pathogenicity in mice by neutralizing suilysin activity. Front. Microbiol., 8: 460.","DOI":"10.3389\/fmicb.2017.00460"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Li G, Wang G, Si X, Zhang X, Liu W, Li L and Wang J (2019). Inhibition of suilysin activity and inflammation by myricetin attenuates Streptococcus suis virulence. Life. Sci., 223: 62-68.","DOI":"10.1016\/j.lfs.2019.03.024"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Li X, Li Q, Zhang Z, Wang C, Huo X, Lai H, Lu H, Lu W, Qian Y, Dong W, Tan C and Liu M (2023). Canagliflozin inhibited the activity of hemolysin and reduced the inflammatory response caused by Streptococcus suis. Int. J. Mol. Sci., 24(17): 13074.","DOI":"10.3390\/ijms241713074"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Liu Y, Yin R, Tian Y, Xu S and Meng X (2024). Curcumin nanopreparations: Recent advance in preparation and application. Biomed. Mater., 19(5): 10.","DOI":"10.1088\/1748-605X\/ad6dc7"},{"key":"ref14","unstructured":"Lu Y, Haiyan L and Shunhang W (2018). Effective of Cucrcumin on Anti-bacterial and Anti-inflammation Induced by Streptococcus Pneumoniae. J. Med. Res., 47: 87-91."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lunha K, Chumpol W, Samngamnim S, Jiemsup S, Assavacheep P and Yongkiettrakul S (2022). Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs in Thailand, 2018\u20132020. Antibiotics, 11: 410.","DOI":"10.3390\/antibiotics11030410"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Meng Y, Lin S, Niu K, Ma Z, Lin H and Fan H (2023). Vimentin affects inflammation and neutrophil recruitment in airway epithelium during Streptococcus suis serotype 2 infection. Vet. Res., 54(1): 7.","DOI":"10.1186\/s13567-023-01135-3"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U and Emerson M (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J. Cereb. Blood Flow Metab., 40(9): 1769-77.","DOI":"10.1177\/0271678X20943823"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Pian Y and Wang Y (2025). Characterization studies on the 05SSU0969 gene of Streptococcus suis serotype 2 in adhesion, anti-phagocytosis and virulence in animal. Microb. Pathog., 205: 107739.","DOI":"10.1016\/j.micpath.2025.107739"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Pinzi L and Rastelli G (2019). Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci., 20(18): 4331.","DOI":"10.3390\/ijms20184331"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Pramitasuri T, Susilawathi N, Tarini N, Sudewi A and Evans M (2023). Cholesterol dependent cytolysins and the brain: Revealing a potential therapeutic avenue for bacterial meningitis. AIMS microbiology, 9(4): 647\u2013667.","DOI":"10.3934\/microbiol.2023033"},{"key":"ref21","unstructured":"Protein Data Bank (2010). Crystal structure of cytotoxin protein suilysin from Streptococcus suis.  Available at: https:\/\/www.rcsb.org\/structure\/3HVN (Accessed 20 October 2023)."},{"key":"ref22","unstructured":"PubChem (2004). Curcumin. Available at:  https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/969516 (Accessed 22 October 2023)"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Takeuchi D, Akeda Y, Nakayama T, Kerdsin A, Sano Y, Kanda T, Hamada S, Dejsirilert S and Oishi K (2014). The contribution of suilysin to the pathogenesis of Streptococcus suis meningitis. J. Infect. Dis., 209: 1509-1519.","DOI":"10.1093\/infdis\/jit661"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Wang G\uff0c Gao Y\uff0c Wu X\uff0c Gao X\uff0c Zhang M\uff0c Liu H and Fang T (2020a). Inhibitory effect of piceatannol on Streptococcus suis infection Both in vitro and in vivo. Front. Microbiol., 11: 593588.","DOI":"10.3389\/fmicb.2020.593588"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Wang G, Liu H, Liu Y, Li H, Li Z, Shao G and Lv X (2020b). Formononetin alleviates Streptococcus suis infection by targeting suilysin. Microb. Pathog., 147(1): 104388.","DOI":"10.1016\/j.micpath.2020.104388"},{"key":"ref26","unstructured":"Wen X, Huang Y, Wang Z and Han C (2014). Effect of curcumin on reducing Streptococcus suis-induced inflammatory response in vitro. Disease Surveillance, 29: 58-61."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Xie S, Zhang Y, Xu L, Li S, Shen X, Li L, Deng X and Zhou Y (2022). Acacetin attenuates Streptococcus suis virulence by simultaneously targeting suilysin and inflammation. Microb. Pathog., 162: 105354.","DOI":"10.1016\/j.micpath.2021.105354"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Xu L, Huang B, Li X, Rao Z, Du H, Xu J and Zhang XC (2010). Crystal structure of cytotoxin protein suilysin from Streptococcus suis. Protein Cell, 1(1): 96-105.","DOI":"10.1007\/s13238-010-0012-3"},{"key":"ref29","unstructured":"Zhan J, Xu k, Zhang L, Xia J, Hong Y, Dong H, Liu Y, Zhou J, Yuan M and Yan L (2022). Verbascoside lowers Streptococcus suis serotype 2 pathogenicity in mice by inhibiting the hemolytic activity of suilysin. Acta Agriculturae Zhejiangensis, 34(8): 1609-1616."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Zhou X, Zhang B, Cui Y, Chen S, Teng Z, Lu G, Wang J and Deng X (2017). Curcumin promotes the clearance of Listeria monocytogenes both in vitro and in vivo by reducing listeriolysin O oligomers. Front. Immunol., 8: 574.","DOI":"10.3389\/fimmu.2017.00574"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:08:40Z","timestamp":1788181720000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":31,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.7.210.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}